Boaz Weinstein’s SBC Medical Group Warrants SBCWW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51K Hold
200,000
﹤0.01% 317
2026
Q1
$60K Hold
200,000
﹤0.01% 298
2025
Q4
$45.9K Hold
200,000
﹤0.01% 279
2025
Q3
$43.4K Hold
200,000
﹤0.01% 259
2025
Q2
$38.6K Hold
200,000
﹤0.01% 249
2025
Q1
$37.2K Hold
200,000
﹤0.01% 186
2024
Q4
$49K Hold
200,000
﹤0.01% 188
2024
Q3
$29.8K Hold
200,000
﹤0.01% 238
2024
Q2
$15.7K Hold
200,000
﹤0.01% 296
2024
Q1
$6.71K Hold
200,000
﹤0.01% 350
2023
Q4
$5.64K Hold
200,000
﹤0.01% 434
2023
Q3
$12K Hold
200,000
﹤0.01% 484
2023
Q2
$11.9K Hold
200,000
﹤0.01% 541
2023
Q1
$10.7K Hold
200,000
﹤0.01% 689
2022
Q4
$11K Buy
200,000
+42,457
+27% +$1.97K ﹤0.01% 793
2022
Q3
$16K Buy
+157,543
New +$13.1K ﹤0.01% 973

Other funds holding SBCWW

Boaz Weinstein's SBCWW Position: Q2 2026 in Review

Boaz Weinstein held its SBC Medical Group Warrants (SBCWW) position steady in Q2 2026 at 200,000 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Boaz Weinstein first reported a position in SBCWW in Q3 2022 and has held it in 16 quarters since. The position peaked at $60K in Q1 2026. 17 funds tracked by Wall St. Rank hold SBCWW as of Q2 2026.

  • Boaz Weinstein held 200,000 shares of SBC Medical Group Warrants worth $51K as of Q2 2026.
  • Boaz Weinstein left its SBC Medical Group Warrants share count unchanged in Q2 2026.
  • SBC Medical Group Warrants made up ﹤0.01% of Boaz Weinstein's portfolio in Q2 2026, its #317 holding.
  • Boaz Weinstein first reported a position in SBC Medical Group Warrants in Q3 2022 and has held it in 16 quarters since.
  • Boaz Weinstein's SBC Medical Group Warrants position peaked at $60K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.